Literature DB >> 34993837

Clinical significance and biological effect of ZFAS1 in Hirschsprung's disease and preliminary exploration of its underlying mechanisms using integrated bioinformatics analysis.

Yujiao Wang1, Peng Cai1, Jian Wang2.   

Abstract

BACKGROUND: The pathogenesis of Hirschprung's disease (HSCR) remains largely unknown. The lncRNA ZNFX1 antisense RNA 1 (ZFAS1) has been found to have vital regulatory roles in a number of diseases. However, the association between ZFAS1 and HSCR has not been reported. AIMS: The present study was aimed at investigating the expression pattern and biological function and underlying mechanisms of ZFAS1 in HSCR.
METHODS: The expression of ZFAS1 was detected in surgical excision samples of 30 children diagnosed with HSCR and 30 control cases. Functional experiments were conducted after over-expression or knockdown of ZFAS1 in human neuronal cell line SH-SY-5Y. Multiple bioinformatics databases and tools were used to explore the potential regulatory mechanisms of ZFAS1 in HSCR.
RESULTS: Compared with the control group, the HSCR group has a significantly higher level of ZFAS1(P = 0.0012). The area under the curve (AUC) of the receiver operating characteristic (ROC) curve was 0.7133 (P = 0.0045), which indicated good biomarker potency of ZFAS1 in HSCR. Functionally, over-expression of ZFAS1 significantly inhibited cell proliferation, whereas knockdown of ZFAS1 promoted cell proliferation and colony formation of SH-SY-5Y cells. Using multiple databases, a competing endogenous RNA (ceRNA) network, containing ZFAS1,13 candidate miRNAs, and 110 potential gene targets, was established. Further enrichment analysis suggested that ZFAS1 may regulate a number of genes and signaling pathways that were crucial for neuron development.
CONCLUSIONS: Our findings revealed that ZFAS1 may participate in the pathogenesis of HSCR through regulating neuron functions. Bioinformatics analysis highlighted an important perspective for the following mechanical researches.
© 2021. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.

Entities:  

Keywords:  Bioinformatics analysis; CeRNA; Hirschprung’s disease; LncRNA; ZFAS1

Year:  2022        PMID: 34993837     DOI: 10.1007/s11845-021-02906-7

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  21 in total

1.  The long noncoding RNA ZFAS1 facilitates bladder cancer tumorigenesis by sponging miR-329.

Authors:  Jin-Shan Wang; Qing-Hong Liu; Xiao-Hua Cheng; Wen-Yuan Zhang; Yong-Chao Jin
Journal:  Biomed Pharmacother       Date:  2018-04-24       Impact factor: 6.529

Review 2.  Genetic impact on the treatment & management of Hirschsprung disease.

Authors:  Sam W Moore
Journal:  J Pediatr Surg       Date:  2016-11-13       Impact factor: 2.545

3.  LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3.

Authors:  Uttam Sharma; Tushar Singh Barwal; Akanksha Khandelwal; Akshay Malhotra; Manjit Kaur Rana; Amrit Pal Singh Rana; Evgeny N Imyanitov; Karen M Vasquez; Aklank Jain
Journal:  Biochimie       Date:  2021-01-09       Impact factor: 4.079

4.  Knockdown of ZFAS1 Inhibits Hippocampal Neurons Apoptosis and Autophagy by Activating the PI3K/AKT Pathway via Up-regulating miR-421 in Epilepsy.

Authors:  Fan Hu; Liang Shao; Ji Zhang; Hong Zhang; An Wen; Ping Zhang
Journal:  Neurochem Res       Date:  2020-07-28       Impact factor: 3.996

Review 5.  Genetic Background of Hirschsprung Disease: A Bridge Between Basic Science and Clinical Application.

Authors:  Afsane Bahrami; Marjan Joodi; Mehrdad Moetamani-Ahmadi; Mina Maftouh; Seyed Mahdi Hassanian; Gordon A Ferns; Amir Avan
Journal:  J Cell Biochem       Date:  2017-06-27       Impact factor: 4.429

6.  Long non-coding RNA H19 contributes to apoptosis of hippocampal neurons by inhibiting let-7b in a rat model of temporal lobe epilepsy.

Authors:  Chun-Lei Han; Ming Ge; Yun-Peng Liu; Xue-Min Zhao; Kai-Liang Wang; Ning Chen; Wei Hu; Jian-Guo Zhang; Liang Li; Fan-Gang Meng
Journal:  Cell Death Dis       Date:  2018-05-23       Impact factor: 8.469

Review 7.  "Too much guts and not enough brains": (epi)genetic mechanisms and future therapies of Hirschsprung disease - a review.

Authors:  Emilie G Jaroy; Lourdes Acosta-Jimenez; Ryo Hotta; Allan M Goldstein; Ragnhild Emblem; Arne Klungland; Rune Ougland
Journal:  Clin Epigenetics       Date:  2019-09-13       Impact factor: 6.551

8.  Upregulation of lncRNA ZFAS1 promotes lung adenocarcinoma progression by sponging miR-1271-5p and upregulating FRS2.

Authors:  Gang Fan; Jin Jiao; Feng Shen; Fulu Chu
Journal:  Thorac Cancer       Date:  2020-06-08       Impact factor: 3.500

Review 9.  Competing Endogenous RNA Regulations in Neurodegenerative Disorders: Current Challenges and Emerging Insights.

Authors:  Yifei Cai; Jun Wan
Journal:  Front Mol Neurosci       Date:  2018-10-05       Impact factor: 5.639

Review 10.  Long noncoding RNAs: functions and mechanisms in colon cancer.

Authors:  Sian Chen; Xian Shen
Journal:  Mol Cancer       Date:  2020-11-28       Impact factor: 27.401

View more
  1 in total

1.  The Classification and Surgical Treatments in Adult Hirschsprung's Disease: A Retrospective Study.

Authors:  Shengzhe Ma; Yue Yu; Anfu Pan; Haifeng Gong; Zheng Lou; Lianjie Liu; Liqiang Hao; Ronggui Meng; Jinke Sui; Wei Zhang
Journal:  Front Med (Lausanne)       Date:  2022-04-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.